TIAA CREF INVESTMENT MANAGEMENT LLC - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 97 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$336,000
+5.7%
62,711
+1.1%
0.00%
Q4 2018$318,000
-74.1%
62,041
-50.9%
0.00%
Q3 2018$1,226,000
+86.3%
126,444
+96.0%
0.00%
Q2 2018$658,000
-63.3%
64,512
-53.2%
0.00%
-100.0%
Q1 2018$1,794,000
+9.3%
137,983
+50.5%
0.00%0.0%
Q4 2017$1,642,000
+2.4%
91,711
+43.5%
0.00%0.0%
Q3 2017$1,604,000
-28.5%
63,915
-31.3%
0.00%
-50.0%
Q2 2017$2,242,000
+55.2%
93,047
+23.9%
0.00%
+100.0%
Q1 2017$1,445,000
+39.6%
75,076
+11.7%
0.00%0.0%
Q4 2016$1,035,000
+39.7%
67,232
+18.1%
0.00%
Q3 2016$741,000
+9.9%
56,930
+17.5%
0.00%
-100.0%
Q2 2016$674,000
+9.2%
48,462
+19.2%
0.00%
Q1 2016$617,000
-20.0%
40,6580.0%0.00%
-100.0%
Q4 2015$771,000
-16.9%
40,658
-16.8%
0.00%0.0%
Q3 2015$928,000
-10.8%
48,855
+21.1%
0.00%0.0%
Q2 2015$1,040,00040,3550.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,609,398$7,821,0001.64%
Telemetry Investments, L.L.C. 242,514$1,179,0001.59%
Omega Fund Management, LLC 2,606,809$12,669,0001.42%
Bruce & Co., Inc. 1,343,312$6,528,0001.39%
1492 Capital Management LLC 488,309$2,373,0001.20%
Abingworth LLP 1,041,131$5,060,0001.15%
Trellus Management Company, LLC 295,000$1,434,0001.04%
Worth Venture Partners, LLC 389,440$1,893,0000.85%
CM Management, LLC 200,000$972,0000.72%
GENERAL AMERICAN INVESTORS CO INC 1,112,658$5,408,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders